Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Anisha Mazumder, Anupma Dwivedi, Wirat Assawapanumat, Rungnapha Saeeng, Witaya Sungkarat & Norased Nasongkla. (2022) In vitro galactose-targeted study of RSPP050-loaded micelles against liver hepatocellular carcinoma. Pharmaceutical Development and Technology 27:4, pages 379-388.
Read now
Read now
Dina Farinha, Michael Migawa, Ana Sarmento-Ribeiro & Henrique Faneca. (2021) A Combined Antitumor Strategy Mediated by a New Targeted Nanosystem to Hepatocellular Carcinoma. International Journal of Nanomedicine 16, pages 3385-3405.
Read now
Read now
Hua Nie, Bo Qiu, Qi-Xuan Yang, Ying Zhao, Xiao-Min Liu, Ying-Ting Zhang, Fu-Lin Liao & Sheng-Yuan Zhang. (2021) Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting in vivo. Journal of Liposome Research 31:1, pages 79-89.
Read now
Read now
Wendu Duan & Yan Liu. (2018) Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. Drug Design, Development and Therapy 12, pages 2149-2161.
Read now
Read now
Zhenghai Zhang, Lei Yang, Jian Hou, Xiaojing Xia, Jing Wang, Qing Ning & Shulong Jiang. (2018) Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 630-640.
Read now
Read now
Shaivee Borker & Varsha Pokharkar. (2018) Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 826-835.
Read now
Read now
Yu Zhang, Tao Zhou, Li Luo, Zheng Cui, Na Wang, Yamin Shu & Kai-Ping Wang. (2018) Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 254-263.
Read now
Read now
Kaiping Wang, Fang Cheng, Xianglin Pan, Tao Zhou, Xiqiu Liu, Ziming Zheng, Li Luo & Yu Zhang. (2017) Investigation of the transport and absorption of Angelica sinensis polysaccharide through gastrointestinal tract both in vitro and in vivo. Drug Delivery 24:1, pages 1360-1371.
Read now
Read now
Articles from other publishers (59)
Sayali Pravin Metkar, Gasper Fernandes, Prerana D. Navti, Ajinkya N. Nikam, Ritu Kudarha, Namdev Dhas, Raviraja N Seetharam, Krishnan Venkata Santhosh, Bola Sadashiva Satish Rao & Srinivas Mutalik. (2023) Nanoparticle drug delivery systems in hepatocellular carcinoma: A focus on targeting strategies and therapeutic applications. OpenNano 12, pages 100159.
Crossref
Crossref
Gopanandan Parthasarathy, Petra Hirsova, Enis Kostallari, Guneet S. Sidhu, Samar H. Ibrahim & Harmeet Malhi. 2011. Comprehensive Physiology. Comprehensive Physiology
4631
4658
.
Gabriela Pastuch-Gawołek, Julia Szreder, Monika Domińska, Mateusz Pielok, Piotr Cichy & Mirosława Grymel. (2023) A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy. Pharmaceutics 15:3, pages 913.
Crossref
Crossref
MG Archana, J Sreekutty, HP Syama, Manu M Joseph, KS Anusree, BS Unnikrishnan, GU Preethi, PL Reshma & TT Sreelekha. (2023) Polysaccharide guided tumor delivery of therapeutics: A bio-fabricated galactomannan-gold nanosystem for augmented cancer therapy. Journal of Drug Delivery Science and Technology 80, pages 104172.
Crossref
Crossref
Ching-Ju Huang, Shao-Jung Hsu, Yi-Chiung Hsu, Liang-Kun Chen, Chuan Li, Hui-Chun Huang & Yu-Hsiang Lee. (2023) Synthesis, characterization, and biological verification of asialoglycoprotein receptor-targeted lipopolysaccharide-encapsulated PLGA nanoparticles for the establishment of a liver fibrosis animal model. Biomaterials Science.
Crossref
Crossref
Assima Rakhimbekova, Anton Lopukhov, Natalia Klyachko, Alexander Kabanov, Timur I. Madzhidov & Alexander Tropsha. (2023) Efficient design of peptide-binding polymers using active learning approaches. Journal of Controlled Release 353, pages 903-914.
Crossref
Crossref
Rabia Aqeel, Nidhi Srivastava & Poonam Kushwaha. (2022) Micelles in Cancer Therapy: An Update on Preclinical and Clinical Status. Recent Patents on Nanotechnology 16:4, pages 283-294.
Crossref
Crossref
Syama HP, Unnikrishnan BS, Sreekutty J, Archana MG, Manu M Joseph, Preethi GU, Anusree KS, Reshma PL, Shiji R & Sreelekha TT. (2022) Bio fabrication of galactomannan capped silver nanoparticles to apprehend Ehrlich ascites carcinoma solid tumor in mice. Journal of Drug Delivery Science and Technology 76, pages 103649.
Crossref
Crossref
Anushree U, Sachin Shetty, Suresh D Kulkarni, Harish Kumar B, K Sreedhara R Pai, Jesil Mathew A, Rajesh Kumar & Sanjay Bharati. (2022) Anticancer therapeutic potential of phosphorylated galactosylated chitosan against N-nitrosodiethyl amine-induced hepatocarcinogenesis. Archives of Biochemistry and Biophysics 728, pages 109375.
Crossref
Crossref
Sathish Sundar Dhilip Kumar & Heidi Abrahamse. (2022) Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy. Frontiers in Chemistry 10.
Crossref
Crossref
Raquibun Nisha, Pranesh Kumar, Umesh Kumar, Nidhi Mishra, Priyanka Maurya, Priya Singh, Heena Tabassum, Alka, Samipta Singh, Anupam Guleria & Shubhini A. Saraf. (2022) Assessment of hyaluronic acid-modified imatinib mesylate cubosomes through CD44 targeted drug delivery in NDEA-induced hepatic carcinoma. International Journal of Pharmaceutics 622, pages 121848.
Crossref
Crossref
Deepa U. Warrier, Anantha K. Dhanabalan, Gunasekaran Krishnasamy, Henry Kolge, Vandana Ghormade, Chandan R. Gupta, Premlata K. Ambre & Ujwala A. Shinde. (2022) Novel derivatives of arabinogalactan, pullulan & lactobionic acid for targeting asialoglycoprotein receptor: Biomolecular interaction, synthesis & evaluation. International Journal of Biological Macromolecules 207, pages 683-699.
Crossref
Crossref
Fei Li, Yunlu Wei, Jing Zhao, Luyao Zhang & Quanhong Li. (2022) In vivo pharmacokinetic study of a Cucurbita moschata polysaccharide after oral administration. International Journal of Biological Macromolecules 203, pages 19-28.
Crossref
Crossref
Ladan Dayani, Mahla Dehghani, Mahmoud Aghaei, Somayeh Taymouri & Azade Taheri. (2022) Preparation and evaluation of targeted albumin lipid nanoparticles with lactobionic acid for targeted drug delivery of sorafenib in hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 69, pages 103142.
Crossref
Crossref
Manish Kumar Gupta, Vipul Sansare, Birendra Shrivastava, Santosh Jadhav & Prashant Gurav. (2022) Fabrication and evaluation of mannose decorated curcumin loaded nanostructured lipid carriers for hepatocyte targeting: In vivo hepatoprotective activity in Wistar rats. Current Research in Pharmacology and Drug Discovery 3, pages 100083.
Crossref
Crossref
Yige Fu, Aishwarya Saraswat, Richa Vartak, Manali Patki & Ketan Patel. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
79
102
.
Prakash Ramalingam, D. S. Prabakaran, Kalaiselvi Sivalingam, V. Uma Maheshwari Nallal, M. Razia, Mayurkumar Patel, Tanvi Kanekar & Dineshkumar Krishnamoorthy. 2022. Emerging Nanomaterials for Advanced Technologies. Emerging Nanomaterials for Advanced Technologies
83
116
.
Anita Bakrania, Gang Zheng & Mamatha Bhat. (2021) Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment. Pharmaceutics 14:1, pages 41.
Crossref
Crossref
Layla Al-mansoori, Philip Elsinga & Sayed K. Goda. (2021) Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy. Biomedicine & Pharmacotherapy 144, pages 112260.
Crossref
Crossref
Keenan J. Mintz & Roger M. Leblanc. (2021) The use of nanotechnology to combat liver cancer: Progress and perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188621.
Crossref
Crossref
Mohammad Heiat, Hamid Hashemi Yeganeh, Seyed Moayed Alavian & Ehsan Rezaie. (2021) Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect. Toxins 13:10, pages 719.
Crossref
Crossref
Mohamed Fawzi Kabil, Maha Nasr & Ibrahim M. El-Sherbiny. (2021) Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 9-37.
Crossref
Crossref
Rishi Sharma, Joshua E. Porterfield, Hyoung-Tae An, Ambar Scarlet Jimenez, Seulki Lee, Sujatha Kannan, Anjali Sharma & Rangaramanujam M. Kannan. (2021) Rationally Designed Galactose Dendrimer for Hepatocyte-Specific Targeting and Intracellular Drug Delivery for the Treatment of Liver Disorders. Biomacromolecules 22:8, pages 3574-3589.
Crossref
Crossref
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar & Md Nurunnabi. (2021) Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 9:14, pages 4821-4842.
Crossref
Crossref
Ehsan kianfar. (2021) Magnetic Nanoparticles in Targeted Drug Delivery: a Review. Journal of Superconductivity and Novel Magnetism 34:7, pages 1709-1735.
Crossref
Crossref
Selvaraj Kunjiappan, Parasuraman Pavadai, Sivakumar Vellaichamy, Sureshbabu Ram Kumar Pandian, Vigneshwaran Ravishankar, Ponnusamy Palanisamy, Saravanan Govindaraj, Gowshiki Srinivasan, Adhvitha Premanand, Murugesan Sankaranarayanan & Panneerselvam Theivendren. (2020) Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review. Drug Development Research 82:3, pages 309-340.
Crossref
Crossref
Yu-Lan Li, Xiao-Min Zhu, Hong Liang, Chris Orvig & Zhen-Feng Chen. (2021) Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery. Current Medicinal Chemistry 28:8, pages 1508-1534.
Crossref
Crossref
Muhammed H. Elnaggar, Abdelrahman I. Abushouk, Ahmed H.E. Hassan, Hadeer M. Lamloum, Amira Benmelouka, Shurouk A. Moatamed, Hossam Abd-Elmegeed, Somia Attia, Aya Samir, Nouran Amr, Dina Johar & Samy Zaky. (2021) Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. Seminars in Cancer Biology 69, pages 91-99.
Crossref
Crossref
Ali Tanhaei, Maryam Mohammadi, Hamed Hamishehkar & Michael R. Hamblin. (2021) Electrospraying as a novel method of particle engineering for drug delivery vehicles. Journal of Controlled Release 330, pages 851-865.
Crossref
Crossref
Mozhgan Razzaghi, Azita Navvabi, Mozafar Bagherzadeh Homaee, Rajesh Sani, Philippe Michaud & Ahmad Homaei. 2021. Microbial Exopolysaccharides as Novel and Significant Biomaterials. Microbial Exopolysaccharides as Novel and Significant Biomaterials
143
199
.
Tarek M. Faris, Gamaleldin I. Harisa, Fars K. Alanazi, Ahmed M. Samy & Fahd A. Nasr. (2020) Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability. Saudi Pharmaceutical Journal 28:12, pages 1851-1867.
Crossref
Crossref
Shiji R.Manu M. Joseph, K. Raveendran Pillai, Preethi G.U.Sreelekha T.T.. (2020) A biocompatible glycol-capped nano-delivery system with stimuli-responsive drug release kinetics abrogates cancer cell survival. International Journal of Biological Macromolecules 165, pages 568-581.
Crossref
Crossref
J. Kenneth Hoober. (2020) ASGR1 and Its Enigmatic Relative, CLEC10A. International Journal of Molecular Sciences 21:14, pages 4818.
Crossref
Crossref
Qi Chang Zheng, Shuai Jiang, Yu Zhe Wu, Dan Shang, Yong Zhang, Shao Bo Hu, Xiang Cheng, Chen Zhang, Ping Sun, Yang Gao, Zi Fang Song & Min Li. (2020) Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Maryam Shetab Boushehri, Dirk Dietrich & Alf Lamprecht. (2020) Nanotechnology as a Platform for the Development of Injectable Parenteral Formulations: A Comprehensive Review of the Know-Hows and State of the Art. Pharmaceutics 12:6, pages 510.
Crossref
Crossref
Samrat Chakraborty, Zewdu Yilma Dlie, Somdyuti Chakraborty, Somdatta Roy, Biswajit Mukherjee, Shila Elizabeth Besra, Saikat Dewanjee, Alankar Mukherjee, Probir Kumar Ojha, Vinay Kumar & Ramkrishna Sen. (2020) Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes. Molecular Therapy - Nucleic Acids 20, pages 34-49.
Crossref
Crossref
Jayshree Ashree, Qi Wang & Yimin Chao. (2019) Glyco-functionalised quantum dots and their progress in cancer diagnosis and treatment. Frontiers of Chemical Science and Engineering 14:3, pages 365-377.
Crossref
Crossref
Mehmet Ozcan, Ozlem Altay, Simon Lam, Hasan Turkez, Yasemin Aksoy, Jens Nielsen, Mathias Uhlen, Jan Boren & Adil Mardinoglu. (2020) Improvement in the Current Therapies for Hepatocellular Carcinoma Using a Systems Medicine Approach. Advanced Biosystems 4:6, pages 2000030.
Crossref
Crossref
Afaf H. Al-Nadaf, Lina A. Dahabiyeh, Sanaa Bardaweel, Nouf N. Mahmoud & Sajidah Jawarneh. (2020) Functionalized mesoporous silica nanoparticles by lactose and hydrophilic polymer as a hepatocellular carcinoma drug delivery system. Journal of Drug Delivery Science and Technology 56, pages 101504.
Crossref
Crossref
Stijn G. Rotman, Keith Thompson, Dirk W. Grijpma, Robert G. Richards, Thomas F. Moriarty, David Eglin & Olivier Guillaume. (2020) Development of bone seeker–functionalised microspheres as a targeted local antibiotic delivery system for bone infections. Journal of Orthopaedic Translation 21, pages 136-145.
Crossref
Crossref
Kenward Vong, Katsunori Tanaka & Koichi Fukase. 2020. Handbook of In Vivo Chemistry in Mice. Handbook of In Vivo Chemistry in Mice
489
529
.
Min Li, Yan Wang, Shuai Jiang, Yang Gao, Weijie Zhang, Shaobo Hu, Xiang Cheng, Chen Zhang, Ping Sun, Wenbo Ke, Guoliang Wang, Zifang Song, Yong Zhang & Qi Chang Zheng. (2020) Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma. Nanomedicine 15:2, pages 145-161.
Crossref
Crossref
Anroop B. Nair, Jigar Shah, Bandar E. Al-Dhubiab, Snehal S. Patel, Mohamed A. Morsy, Vimal Patel, Vishal Chavda, Shery Jacob, Nagaraja Sreeharsha, Pottathil Shinu, Mahesh Attimarad & Katharigatta N. Venugopala. (2019) Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma. Molecules 24:24, pages 4566.
Crossref
Crossref
Yongbing Sun, Wen Ma, Yuanyuan Yang, Mengxue He, Aimin Li, Lei Bai, Bin Yu & Zhiqiang Yu. (2019) Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy. Asian Journal of Pharmaceutical Sciences 14:6, pages 581-594.
Crossref
Crossref
Hua Wang, Yang Liu, Ming Xu & Jianjun Cheng. (2019) Azido-galactose outperforms azido-mannose for metabolic labeling and targeting of hepatocellular carcinoma. Biomaterials Science 7:10, pages 4166-4173.
Crossref
Crossref
Anca Giorgiana Grigoras. (2019) Drug delivery systems using pullulan, a biocompatible polysaccharide produced by fungal fermentation of starch. Environmental Chemistry Letters 17:3, pages 1209-1223.
Crossref
Crossref
Vahid Taghipour-Sabzevar, Tahere Sharifi & Mehrdad Moosazadeh Moghaddam. (2019) Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents. Therapeutic Delivery 10:8, pages 527-550.
Crossref
Crossref
Gang Zheng, Meizhu Zheng, Ben Yang, Hui Fu & Yongqing Li. (2019) Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Biomedicine & Pharmacotherapy 116, pages 109006.
Crossref
Crossref
Kevin R. Diaz-Galvez, Nayelli G. Teran-Saavedra, Alexel J. Burgara-Estrella, Daniel Fernandez-Quiroz, Erika Silva-Campa, Monica Acosta-Elias, Hector M. Sarabia-Sainz, Martín R. Pedroza-Montero & Jose A. Sarabia-Sainz. (2019) Specific capture of glycosylated graphene oxide by an asialoglycoprotein receptor: a strategic approach for liver-targeting. RSC Advances 9:18, pages 9899-9906.
Crossref
Crossref
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2019. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy
79
106
.
Saugandha Das, Pawan Kudale, Prajakta Dandekar & Padma V. Devarajan. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
353
381
.
Dhanashree H. Surve, Prajakta Dandekar, Padma V. Devarajan & Anil B. Jindal. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
3
41
.
Anca Giorgiana Grigoras. 2019. Pharmaceuticals from Microbes. Pharmaceuticals from Microbes
99
141
.
Xin Xia, Nicolette Pollock, Jiehua Zhou & John Rossi. 2019. Oligonucleotide-Based Therapies. Oligonucleotide-Based Therapies
17
50
.
Sipei Zhang, Dan Wang, Yating Li, Ling Li, Hongli Chen, Qingqing Xiong, Yuanyuan Liu & Yinsong Wang. (2018)
pH- and redox-responsive nanoparticles composed of charge-reversible pullulan-based shells and disulfide-containing poly(
ß
-amino ester) cores for co-delivery of a gene and chemotherapeutic agent
. Nanotechnology 29:32, pages 325101.
Crossref
Crossref
Lorena Rico, Michael E. Østergaard, Melanie Bell, Punit P. Seth & Stephen Hanessian. (2018) Studies directed toward the asialoglycoprotein receptor mediated delivery of 5-fluoro-2′-deoxyuridine for hepatocellular carcinoma. Bioorganic & Medicinal Chemistry Letters 28:15, pages 2652-2654.
Crossref
Crossref
H.A. Khan, M.K. Sakharkar, A. Nayak, U. Kishore & A. Khan. 2018. Nanobiomaterials. Nanobiomaterials
357
384
.
Manu M. Joseph, Jyothi B. Nair, Kaustabh Kumar Maiti & Sreelekha Therakathinal T. (2017) Plasmonically Enhanced Galactoxyloglucan Endowed Gold Nanoparticles Exposed Tumor Targeting Biodistribution Envisaged in a Surface-Enhanced Raman Scattering Platform. Biomacromolecules 18:12, pages 4041-4053.
Crossref
Crossref
Rosa Maria Iacobazzi, Letizia Porcelli, Angela Assunta Lopedota, Valentino Laquintana, Antonio Lopalco, Annalisa Cutrignelli, Emiliano Altamura, Roberta Di Fonte, Amalia Azzariti, Massimo Franco & Nunzio Denora. (2017) Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers. International Journal of Pharmaceutics 528:1-2, pages 485-497.
Crossref
Crossref